» Articles » PMID: 36613909

Biochemical, Clinical, and Genetic Characteristics of Mexican Patients with Primary Hypertriglyceridemia, Including the First Case of Hyperchylomicronemia Syndrome Due to GPIHBP1 Deficiency

Abstract

Primary hypertriglyceridemia (PHTG) is characterized by a high concentration of triglycerides (TG); it is divided between familial hyperchylomicronemia syndrome and multifactorial chylomicronemia syndrome. In Mexico, hypertriglyceridemia constitutes a health problem in which the genetic bases have been scarcely explored; therefore, our objective was to describe biochemical-clinical characteristics and variants in the and genes in patients with primary hypertriglyceridemia. Thirty DNA fragments were analyzed using PCR and Sanger sequencing in 58 unrelated patients. The patients' main clinical-biochemical features were hypoalphalipoproteinemia (77.6%), pancreatitis (18.1%), and a TG median value of 773.9 mg/dL. A total of 74 variants were found (10 in , 16 in , 34 in , and 14 in ), of which 15 could be involved in the development of PHTG: 3 common variants with significative odds and 12 heterozygous rare pathogenic variants distributed in 12 patients. We report on the first Mexican patient with hyperchylomicronemia syndrome due to GPIHBP1 deficiency caused by three variants: p.R145*, p.A154_G155insK, and p.A154Rfs*152. Moreover, eleven patients were heterozygous for the rare variants described as causing PHTG and also presented common variants of risk, which could partially explain their phenotype. In terms of findings, two novel genetic variants, c.-40_-22del and p.G242Dfs*10 were identified.

Citing Articles

The role of lipase maturation factor 1 in hypertriglyceridaemia and atherosclerosis: An update.

Dabravolski S, Churov A, Sukhorukov V, Kovyanova T, Beloyartsev D, Lyapina I SAGE Open Med. 2024; 12:20503121241289828.

PMID: 39483624 PMC: 11526315. DOI: 10.1177/20503121241289828.

References
1.
Farnier M, Roth E, Gil-Extremera B, Mendez G, Macdonell G, Hamlin C . Efficacy and safety of the coadministration of ezetimibe/simvastatin with fenofibrate in patients with mixed hyperlipidemia. Am Heart J. 2007; 153(2):335.e1-8. DOI: 10.1016/j.ahj.2006.10.031. View

2.
Tietjen I, Hovingh G, Singaraja R, Radomski C, McEwen J, Chan E . Increased risk of coronary artery disease in Caucasians with extremely low HDL cholesterol due to mutations in ABCA1, APOA1, and LCAT. Biochim Biophys Acta. 2011; 1821(3):416-24. DOI: 10.1016/j.bbalip.2011.08.006. View

3.
Wierzbicki A, Poston R, Ferro A . The lipid and non-lipid effects of statins. Pharmacol Ther. 2003; 99(1):95-112. DOI: 10.1016/s0163-7258(03)00055-x. View

4.
Johansen C, Wang J, McIntyre A, Martins R, Ban M, Lanktree M . Excess of rare variants in non-genome-wide association study candidate genes in patients with hypertriglyceridemia. Circ Cardiovasc Genet. 2011; 5(1):66-72. PMC: 3288444. DOI: 10.1161/CIRCGENETICS.111.960864. View

5.
Hegele R, Berberich A, Ban M, Wang J, Digenio A, Alexander V . Clinical and biochemical features of different molecular etiologies of familial chylomicronemia. J Clin Lipidol. 2018; 12(4):920-927.e4. DOI: 10.1016/j.jacl.2018.03.093. View